Patents by Inventor Christiane Bauerlein

Christiane Bauerlein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170313661
    Abstract: A method of treating cancer in which a compound that inhibits the expression, production or release of IL-10 by immune cells is combined with a compound that stimulates the production of IL-12 when given in combination with, or in the presence of TNFa. Said method is effective when provided in addition to standard therapies, notably chemotherapy using cytotoxic drugs and other forms of immune therapy including therapeutic vaccines.
    Type: Application
    Filed: April 10, 2017
    Publication date: November 2, 2017
    Inventors: Michael W. Burnet, Jan-Hinrich Guse, Christiane Bauerlein, Ulrike Hahn
  • Patent number: 9617221
    Abstract: A method of treating cancer in which a compound that inhibits the expression, production or release of IL-10 by immune cells is combined with a compound that stimulates the production of IL-12 when given in combination with, or in the presence of TNFa. Said method is effective when provided in addition to standard therapies, notably chemotherapy using cytotoxic drugs and other forms of immune therapy including therapeutic vaccines.
    Type: Grant
    Filed: August 15, 2012
    Date of Patent: April 11, 2017
    Assignee: Synovo GmbH
    Inventors: Michael W. Burnet, Jan-Hinrich Guse, Christiane Bauerlein, Ulrike Hahn
  • Patent number: 9145436
    Abstract: The invention provides novel compounds and compositions and methods for making and using the compounds and compositions.
    Type: Grant
    Filed: October 10, 2011
    Date of Patent: September 29, 2015
    Inventors: Michael W. Burnet, Jan-Hinrich Guse, Christiane Bauerlein, Mary Eggers
  • Publication number: 20140031307
    Abstract: The invention provides novel compounds and compositions and methods for making and using the compounds and compositions.
    Type: Application
    Filed: October 10, 2011
    Publication date: January 30, 2014
    Applicant: SYNOVO GMBH
    Inventors: Michael W. Burnet, Jan-Hinrich Guse, Christiane Bauerlein, Mary Eggers
  • Publication number: 20130045938
    Abstract: A method of treating cancer in which a compound that inhibits the expression, production or release of IL-10 by immune cells is combined with a compound that stimulates the production of IL-12 when given in combination with, or in the presence of TNFa. Said method is effective when provided in addition to standard therapies, notably chemotherapy using cytotoxic drugs and other forms of immune therapy including therapeutic vaccines.
    Type: Application
    Filed: August 15, 2012
    Publication date: February 21, 2013
    Applicant: Synovo GmbH
    Inventors: Michael W. Burnet, Jan-Hinrich Guse, Christiane Bauerlein, Ulrike Hahn